MTNB — Matinas BioPharma Holdings, Inc.

MTNBMatinas BioPharma Holdings, Inc.

AMEX · US · Healthcare · Biotechnology · matinasbiopharma.com

0.8600USD+6.17%Mkt Cap: 5.51M USDP/E: —Last update: 2026-06-01

Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, identifies and develops pharmaceutical products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology p…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap5.51M USD

Enterprise Value1.44M USD

Revenue (TTM)—

Gross Profit-85.00K USD

Net Income (TTM)-10.35M USD

Revenue/Share—

Last Price0.8600 USD

Fiscal Year EndDec 2025

MR QuarterDec 2025

Employees2

CountryUS

SectorHealthcare

IndustryBiotechnology

ISINUS5768101058

Valuation

P/E (Trailing)—

P/E (Forward)-0.27

PEG—

EV/EBITDA-0.21

EV/Revenue—

P/S—

P/B1.07

EPS (TTM)-1.97

EPS (Forward)-3.00

52W Range

0.480015% of range3.090

52W High3.090 USD

52W Low0.4800 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-214.18%

ROA-143.52%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-7.01M USD

CapEx (TTM)—

FCF Margin—

FCF Yield-60.62%

Net Debt-2.65M USD

Net Debt/EBITDA0.38

Balance Sheet

Debt/Equity0.28

Current Ratio2.79

Quick Ratio2.73

Book Value/Sh0.7540 USD

Cash/Share0.6240 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:50

Split DateSep 3, 2024

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.6.41M

Float5.23M

Insiders22.11%

Institutions7.04%

Short Interest

Short Ratio0.1d

Short % Float0.05%

Short % Out.0.05%

Shares Short3.51K

Short (prev mo.)7.18K

Technical

SMA 500.5945 (+44.7%)

SMA 2001.007 (-14.6%)

Beta1.62

S&P 52W Chg27.94%

Avg Vol (30d)260.61K

Avg Vol (10d)701.55K

Technical Indicators

RSI (14)73.4

MACD0.0433

MACD Signal0.0226

MACD Hist.+0.0207

BB Upper0.8046 USD

BB Middle0.6532 USD

BB Lower0.5019 USD

BB Width46.34%

ATR (14)0.0808 USD

Vol Ratio (20d)0.11x